Compare Stocks

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Carube Copper Corp., an exploration stage junior mining company, engages in the identification, acquisition, evaluation, and exploration of mineral properties in Jamaica and Canada. The company owns 11 copper and gold exploration licenses in Jamaica covering an area of 535 square kilometers. It primarily holds interest in the Bellas Gate project that consists of Bellas Gate and Browns Hall special exclusive prospecting licenses covering an area of 84 square kilometers located in Jamaica. The company was formerly known as Carube Resources Inc. and changed its name to Carube Copper Corp. in June 2015. Carube Copper Corp. is based in Toronto, Canada.

The GGM Macro Alignment ETF (GGM) is an exchange-traded fund that mostly invests in total market equity. The fund is an actively managed fund-of-funds that seeks long-term capital appreciation by dynamically shifting investments best suited for the prevailing macroeconomic environment. Holdings consist of five underlying ETFs representing distinct US equity market sectors, sub-sectors, and market styles, including fixed income. GGM was launched on Sep 27, 2023 and is issued by GGM.